| Literature DB >> 36160911 |
Răzvan Cătălin Popescu1,2, Nicoleta Leopa1,2, Eugen Dumitru2,3, Anca Florentina Mitroi4, Cristina Tocia2,3, Andrei Dumitru2,3, Costel Brînzan4, Florin Botea5.
Abstract
Diabetes mellitus (DM) promotes colorectal cancer (CRC) carcinogenesis through complex processes and is considered as an independent risk factor for cancer in general and for CRC in particular. Diabetic patients have complications in the postoperative period following CRC surgery. The aim of the present study was to explore the effect of type II DM (T2DM) on postoperative outcomes for CRC compared with non-diabetic patients. The present study analyzed the data from patients admitted to the General Surgery Department, Emergency Hospital of Constanța (Romania) diagnosed with CRC and DM compared with a control group (patients with CRC, without DM, recruited in the same period and frequency matched to cases by number, sex and age) analyzing patient comorbidities and postoperative complications. A total of 61 patients had undergone surgery for CRC and met the inclusion criteria in the present study conducted during September 2020-2021. A total of 30 patients associated T2DM. Diabetic patients have been associated with more comorbidities than non-diabetics; the age-adjusted Charlson comorbidity index score ≥6 was identified in 90% of diabetic patients compared with 45.2% of controls. Grade III Clavien-Dindo classification was observed in 13.3% diabetic patients compared with 3.2% of non-diabetic patients. Additionally, a higher rate of urinary and pulmonary complications (6.7 vs. 3.2% in controls respectively) in patients with diabetes was found. Postoperative hospitalization was prolonged in diabetic patients (P=0.042). Univariate and multivariate analyses revealed that the laparoscopic approach for diabetic patients was found to be associated with <grade III Clavien-Dindo classification (P=0.040) and the absence of surgical site infection (P=0.040). Diabetes predisposes patients to numerous postoperative complications following CRC surgery and postoperative therapeutic conduct must be personalized to prevent possible postoperative complications following CRC. Copyright: © Popescu et al.Entities:
Keywords: colorectal cancer; diabetes mellitus; laparoscopy; postoperative complications; surgery
Year: 2022 PMID: 36160911 PMCID: PMC9469087 DOI: 10.3892/etm.2022.11548
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.751
Baseline demographics, comorbidity and surgical procedure of the patients.
| CRC cases (n=61) | |||
|---|---|---|---|
| Variable | T2DM (n=30) | No T2DM (n=31) | P-value |
| Age, years[ | 69.90±8.36 | 66.10±11.69 | 0.139 |
| Sex, n (%) | 0.869 | ||
| Male | 19 (63.3) | 19 (61.3) | |
| Female | 11 (36.7) | 12 (38.7) | |
| Smoker[ | 9(30) | 7 (22.6) | 0.510 |
| Habitual alcohol use[ | 6(20) | 2 (6.5) | 0.110 |
| BMI, kg/m²[ | 30.75±3.90 | 28.61±4.65 | 0.023 |
| HbA1c[ | 6.86±0.73 | 5.01±0.39 | <0.001 |
| Glu, mg/dl[ | 143.29±14.59 | 87.06±9.40 | <0.001 |
| CEA, ng/ml[ | 102.90±49.66 | 105.92±48.24 | 0.710 |
| CA19-9, U/ml[ | 106.78±39.75 | 286.39±50.35 | 0.015 |
| ACCI[ | 7±1.48 | 5.06±1.63 | 0.004 |
| 0-1, n (%) | 0 (0) | 0 (0) | |
| 2-3, n (%) | 0 (0) | 6 (19.6) | |
| 4-5, n (%) | 3(10) | 11 (35.5) | |
| ≥6, n (%) | 27(90) | 14 (45.2) | |
| Surgical approach | 0.457 | ||
| Laparoscopy | 8 (26.7) | ||
| Open | 22 (73.3) | ||
| Operation time, min[ | 191.83±20.78 | 196.15±25.67 | 0.013 |
aMean ± standard deviation.
bSmoker was defined as smoking of ≥10 cigarettes daily.
cAlcohol consumption was defined as ≥1 drink per day for women and ≥2 drinks per day for men. ACCI, age-adjusted Charlson comorbidity index; BMI, body mass index; CA19-9, cancer antigen 19-9; CEA, carcinoembryonic antigen; CRC, colorectal cancer; Glu, glucose; HbA1c, hemoglobin A1c; T2DM, type II diabetes mellitus.
Postoperative outcomes of patients CRC with or without T2DM.
| CRC cases (n=61) | ||||
|---|---|---|---|---|
| Variable | T2DM; n=30 (%) | No T2DM; n=31 (%) | OR (95%CI) | P-value |
| Any postoperative complication | 9(30) | 3 (9.7) | 0.250 (0.060-1.038) | 0.046 |
| Clavien-Dindo classification | ||||
| Grade I | 0 (0) | 1 (3.2) | 1.033 (0.969-1.102) | 0.242 |
| Grade II | 5 (16.7) | 1 (3.2) | 0.167 (0.018-1.522) | 0.078 |
| Grade IIIA | 3(10) | 1 (3.2) | 0.300 (0.029-3.059) | 0.285 |
| Grade IIIB | 1 (3.3) | 0 (0) | 0.967 (0.905-1.033) | 0.305 |
| Grade IVA | 0 (0) | 0 (0) | - | ns |
| Grade IVB | 0 (0) | 0 (0) | - | ns |
| Grade V | 0 (0) | 0 (0) | - | ns |
| Reoperation | 1 (3.3) | 0 (0) | 0.967 (0.905-1.033) | 0.305 |
| Anastomotic leakage | 1 (3.3) | 0 (0) | 0.967 (0.905-1.033) | 0.305 |
| Infectious complications | ||||
| Surgical site infection | 3(10) | 1 (3.2) | 0.300 (0.029-3.059) | 0.285 |
| Intra-abdominal abscess | 1 (3.3) | 0 (0) | 0.967 (0.905-1.033) | 0.305 |
| Septicemia | 0 (0) | 0 (0) | - | ns |
| Systemic complications | ||||
| Urinary complications | 2 (6.7) | 1 (3.2) | 0.467 (0.40-5.435) | 0.531 |
| Pulmonary complications | 2 (6.7) | 1 (3.2) | 0.467 (0.40-5.435) | 0.531 |
| Cardiac complications | 0 (0) | 1 (3.2) | 1.033 (0.969-1.102) | 0.242 |
| Mechanical failure of wound healing | 2 (6.7) | 0 (0) | 0.933 (0.848-1.027) | 0.088 |
| Ileus | 7 (23.3) | 2 (6.5) | 0.227 (0.043-1.197) | 0.057 |
| 1 (3.3) | 0 (0) | 0.967 (0.905-1.033) | 0.305 | |
| Postoperative hospital stay[ | 7.03±1.21 | 6.13±0.88 | - | 0.042 |
| 30-day mortality | 0 (0) | 0 (0) | - | ns |
| Readmission | 0 (0) | 0 (0) | - | ns |
aMean ± standard deviation. CI, confidence interval; CRC, colorectal cancer; ns, not significant; OR, odds ratio; T2DM, type II diabetes mellitus.
Histopathological findings.
| CRC cases (n=31) | ||||
|---|---|---|---|---|
| Variable | T2DM; n=30 (%) | No T2DM; n=31 (%) | OR (95%CI) | P-value |
| Tumor site | ||||
| Right-sided | 7 (23.3) | 8 (25.8) | (Reference) | - |
| Left-sided | 14 (46.7) | 9(29) | (Reference) | - |
| Rectum | 9(30) | 14 (45.2) | 0.222 | |
| T | ||||
| T1-2 | 9(30) | 11 (35.5) | (Reference) | - |
| T2-3 | 21(70) | 20 (64.5) | 0.779 (0.267-2.278) | 0.648 |
| N | ||||
| N0 | 16 (53.3) | 12 (38.7) | (Reference) | - |
| N+ | 16 (46.7) | 19 (61.3) | 1.810 (0.654-5.009) | 0.252 |
| M | ||||
| M0 | 27(90) | 29 (93.5) | (Reference) | - |
| M+ | 3(10) | 2 (6.5) | 0.621 (0.096-4.005) | 0.614 |
| Tumor stage | ||||
| 1-2 | 15(50) | 12 (38.7) | (Reference) | - |
| 3-4 | 15(50) | 19 (61.3) | 1.583 (0.579-4.378) | 0.375 |
CI, confidence interval; CRC, colorectal cancer; M, pathological metastasis; N, pathological node; OR, odds ratio; T, pathological tumor; T2DM, type II diabetes mellitus.
Univariate and multivariate analysis for patients with T2DM and CRC depending on the type of surgical approach.
| Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|
| Variable | Laparoscopy; n=8 (%) | Open; n=22 (%) | P-value | OR (95%CI) | P-value |
| ACCI | |||||
| <6 | 1 (12.5) | 2 (9.1) | |||
| ≥6 | 7 (87.5) | 20 (90.9) | 0.787 | 1.429 (0.112-18.298) | 0.784 |
| Clavien-Dindo classification | |||||
| < Grade 3 | 8(100) | 19 (86.4) | |||
| ≥ Grade 3 | 0 | 3 (13.6) | 0.159 | 1.158 (0.981-1.367) | 0.040 |
| Surgical site infection | |||||
| Absent | 8(100) | 19 (86.4) | |||
| Present | 0 (18.4) | 3 (13.6) | 0.159 | 1.158 (0.981-1.367) | 0.040 |
| Anastomotic leakage | |||||
| Absent | 8 | 21 (95.5) | |||
| Present | 0 | 1 (4.5) | 0.211 | 0.421 (0.290-0.611) | 0.271 |
| Pulmonary complications | |||||
| Absent | 8(100) | 20 (90.9) | |||
| Present | 0 | 2 (9.1) | 0.224 | 0.447 (0.314-0.637) | 0.144 |
| Ileus | |||||
| Absent | 7 (87.5) | 16 (72.7) | |||
| Present | 1 (12.5) | 6 (27.3) | 0.008 | 0.237 (0.134-0.419) | 0.250 |
| Operation time, min[ | 218.75±18.07 | 182.05±10.54 | 0.002 | ||
| No of lymph nodes retrieved[ | 18.63±8.94 | 16±6.34 | 0.258 | ||
| Postoperative hospital stay[ | 6.63±0.91 | 7.64±2.46 | 0.273 | ||
aMean ± standard deviation. ACCI, age-adjusted Charlson comorbidity index; CI, confidence interval; CRC, colorectal cancer; OR, odds ratio; T2DM, type II diabetes mellitus.